These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 23717429)

  • 1. Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring.
    Kim H; Kim K; Yu SJ; Jang ES; Yu J; Cho G; Yoon JH; Kim Y
    PLoS One; 2013; 8(5):e63468. PubMed ID: 23717429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
    Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
    Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma.
    Zhang A; Yin C; Wang Z; Zhang Y; Zhao Y; Li A; Sun H; Lin D; Li N
    J Int Med Res; 2016 Dec; 44(6):1414-1423. PubMed ID: 27885040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.
    Chen L; Ho DW; Lee NP; Sun S; Lam B; Wong KF; Yi X; Lau GK; Ng EW; Poon TC; Lai PB; Cai Z; Peng J; Leng X; Poon RT; Luk JM
    Ann Surg Oncol; 2010 Sep; 17(9):2518-25. PubMed ID: 20354800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of α-fetoprotein and glypican-3 mRNAs in the peripheral blood of hepatocellular carcinoma patients by using multiple FQ-RT-PCR.
    Yan D; He Q; Chen Y; Wang L; Zhang X
    J Clin Lab Anal; 2011; 25(2):113-7. PubMed ID: 21438004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma.
    Qi Y; Xu F; Chen L; Li Y; Xu Z; Zhang Y; Wei W; Su N; Zhang T; Fan F; Wang X; Qin X; Zhang L; Liu Y; Xu P
    Oncotarget; 2016 Oct; 7(42):68242-68252. PubMed ID: 27626164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the Dongfeng-Tongji cohort study.
    Wang K; Bai Y; Chen S; Huang J; Yuan J; Chen W; Yao P; Miao X; Wang Y; Liang Y; Zhang X; He M; Yang H; Guo H; Wei S
    Cancer Med; 2018 Jun; 7(6):2691-2698. PubMed ID: 29696820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma.
    Sun Y; Gao G; Cai J; Wang Y; Qu X; He L; Liu F; Zhang Y; Lin K; Ma S; Yang X; Qian X; Zhao X
    Carcinogenesis; 2013 Mar; 34(3):595-604. PubMed ID: 23188673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Assay for AFP-L3 by Using Multiple Reaction Monitoring-Mass Spectrometry for Diagnosing Hepatocellular Carcinoma.
    Kim H; Sohn A; Yeo I; Yu SJ; Yoon JH; Kim Y
    Clin Chem; 2018 Aug; 64(8):1230-1238. PubMed ID: 29875214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the role of interleukin-6 in diagnosis of hepatocellular carcinoma.
    El-Folly RF; El-Kabarity RH; Arafa NA
    Egypt J Immunol; 2010; 17(2):11-22. PubMed ID: 23082483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
    Beale G; Chattopadhyay D; Gray J; Stewart S; Hudson M; Day C; Trerotoli P; Giannelli G; Manas D; Reeves H
    BMC Cancer; 2008 Jul; 8():200. PubMed ID: 18638391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
    Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
    World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lectin-coupled, targeted proteomic mass spectrometry (MRM MS) platform for identification of multiple liver cancer biomarkers in human plasma.
    Ahn YH; Shin PM; Oh NR; Park GW; Kim H; Yoo JS
    J Proteomics; 2012 Sep; 75(17):5507-15. PubMed ID: 22789673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma.
    Feng H; Li B; Li Z; Wei Q; Ren L
    BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive Detection of Hepatocellular Carcinoma with Circulating Tumor DNA Features and α-Fetoprotein.
    Meng Z; Ren Q; Zhong G; Li S; Chen Y; Wu W; Feng Y; Mao M; Zhang F; Long G
    J Mol Diagn; 2021 Sep; 23(9):1174-1184. PubMed ID: 34182124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.
    Nakatsura T; Yoshitake Y; Senju S; Monji M; Komori H; Motomura Y; Hosaka S; Beppu T; Ishiko T; Kamohara H; Ashihara H; Katagiri T; Furukawa Y; Fujiyama S; Ogawa M; Nakamura Y; Nishimura Y
    Biochem Biophys Res Commun; 2003 Jun; 306(1):16-25. PubMed ID: 12788060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma.
    Yan L; Chen Y; Zhou J; Zhao H; Zhang H; Wang G
    Int J Infect Dis; 2018 Feb; 67():92-97. PubMed ID: 29229500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five Novel Oncogenic Signatures Could Be Utilized as AFP-Related Diagnostic Biomarkers for Hepatocellular Carcinoma Based on Next-Generation Sequencing.
    Yu Z; Wang R; Chen F; Wang J; Huang X
    Dig Dis Sci; 2018 Apr; 63(4):945-957. PubMed ID: 29442275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein profiling in hepatocellular carcinoma by label-free quantitative proteomics in two west African populations.
    Fye HK; Wright-Drakesmith C; Kramer HB; Camey S; Nogueira da Costa A; Jeng A; Bah A; Kirk GD; Sharif MI; Ladep NG; Okeke E; Hainaut P; Taylor-Robinson SD; Kessler BM; Mendy ME
    PLoS One; 2013; 8(7):e68381. PubMed ID: 23935864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.